Hatipoglu, T. Et Al. 2020. Ultra-Deep Targeted Sequencing Reveals Cancer-Associated, Prognostically Significant Mutations in Circulating Cell-Free DNA in Treatment-Naive Patients with Follicular Lymphoma. BLOOD , vol.136 .

Hatipoglu, T., Esmeray, E., Hu, X., Yuan, H., Danyeli, A. E., Seyhanli, A., ... Suzek, T. O.(2020). Ultra-Deep Targeted Sequencing Reveals Cancer-Associated, Prognostically Significant Mutations in Circulating Cell-Free DNA in Treatment-Naive Patients with Follicular Lymphoma. BLOOD , vol.136.

Hatipoglu, Tevfik Et Al. "Ultra-Deep Targeted Sequencing Reveals Cancer-Associated, Prognostically Significant Mutations in Circulating Cell-Free DNA in Treatment-Naive Patients with Follicular Lymphoma," BLOOD , vol.136, 2020

Hatipoglu, Tevfik Et Al. "Ultra-Deep Targeted Sequencing Reveals Cancer-Associated, Prognostically Significant Mutations in Circulating Cell-Free DNA in Treatment-Naive Patients with Follicular Lymphoma." BLOOD , vol.136, 2020

Hatipoglu, T. Et Al. (2020) . "Ultra-Deep Targeted Sequencing Reveals Cancer-Associated, Prognostically Significant Mutations in Circulating Cell-Free DNA in Treatment-Naive Patients with Follicular Lymphoma." BLOOD , vol.136.

@article{article, author={Tevfik Hatipoglu Et Al. }, title={Ultra-Deep Targeted Sequencing Reveals Cancer-Associated, Prognostically Significant Mutations in Circulating Cell-Free DNA in Treatment-Naive Patients with Follicular Lymphoma}, journal={BLOOD}, year=2020}